Shennon Biotechnologies raised $12 million in funding.
- Amount
- $12M
- Announced
- 14 September 2026
- Investors
- Future Ventures, NextGen Venture Partners, Samos Investments, Atypical Ventures, Saras Capital, DCVC, Foundation Capital, AV8 Ventures
- Use of funds
- Advance its proprietary T-cell engager platform and newly disclosed oncology pipeline toward the clinic.
- Checked
- Amount and date checked against the press source